Cyld | CYLD lysine 63 deubiquitinase
Physiological systems
16 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Immune system Hematopoietic system Behavior/neurological
13 No significant impact
8 Not tested
Data collections
Gene metrics:5Significant phenotypes
6Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| decreased locomotor activity | 8 supporting datasets | Cyldem2(IMPC)Marc | homozygote | Early adult | 1.43x10-11 | ||
| increased basophil cell number | 2 supporting datasets | Cyldem2(IMPC)Marc | homozygote | Early adult | 1.96x10-35 | ||
| decreased exploration in new environment | 1 supporting dataset | Cyldem2(IMPC)Marc | homozygote | Early adult | 8.32x10-6 | ||
| increased grip strength | 1 supporting dataset | Cyldem2(IMPC)Marc | homozygote | Early adult | 5.97x10-9 | ||
| increased eosinophil cell number | 2 supporting datasets | Cyldem2(IMPC)Marc | homozygote | Early adult | 1.35x10-12 |
| | | | | | | | | | |
External links
No external links available for Cyld.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.